elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26828464-409A5341-279F-4C3D-B731-F5F4DF9F31AE
Q26828464-409A5341-279F-4C3D-B731-F5F4DF9F31AE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26828464-409A5341-279F-4C3D-B731-F5F4DF9F31AE
Anti-HIV-1 nanotherapeutics: promises and challenges for the future
P2860
Q26828464-409A5341-279F-4C3D-B731-F5F4DF9F31AE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26828464-409A5341-279F-4C3D-B731-F5F4DF9F31AE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c90adaffbc85afca2896d7296d84124c0e74f633
P2860
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity.